Mayo Clinic Studying Genomics of Antiplatelet Heart Medication

ROCHESTER, Minn. — Which antiplatelet medication is best after a coronary stent? The Tailored Antiplatelet Therapy to Lessen Outcomes After Percutaneous Coronary Intervention (TAILOR-PCI) Study examines whether prescribing heart medication based on a patient’s CYP2C19 genotype will help prevent heart attack, str oke, unstable angina, and cardiovascular death in patients who undergo percutaneous coronary intervention (PCI), [...]
Source: Mayo Clinic Research News - Category: Research Source Type: news